Asymchem Laboratories (Tianjin) Co., Ltd. Share Price

Stocks

002821

CNE100002BZ6

Pharmaceuticals

OTC Markets Traded
End-of-day quote 12/08/2026 5-day change 1st Jan Change
175.00 CNY -0.36% Intraday chart for Asymchem Laboratories (Tianjin) Co., Ltd. +7.11% +88.31%

Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 6.11TCr 905.78Cr 784.76Cr 735.28Cr 670.65Cr 1.26TCr 86TCr 1.28TCr 8.65TCr 3.38TCr 43TCr 3.4TCr 3.33TCr 1,44200Cr P/E 2026 *
45x
P/E 2027 * 36x
Enterprise Value 5.6TCr 830.9Cr 719.89Cr 674.5Cr 615.22Cr 1.16TCr 79TCr 1.17TCr 7.93TCr 3.1TCr 40TCr 3.12TCr 3.05TCr 1,32300Cr EV / Sales 2026 *
6.93x
EV / Sales 2027 * 5.83x
Free-Float
61.14%
Yield 2026 *
0.84%
Yield 2027 * 1.03%
31/07 Asymchem Laboratories to Subscribe for Subsidiary's New Shares for 1.05 Billion Yuan; Shares Up 6% MT
30/07 Shanghai Asymchem Biotechnology Development Co., Ltd. announced that it expects to receive CNY 1.239699995 billion in funding from Asymchem Laboratories Co., Ltd., Suzhou Gao Ling Qirui Healthcare Investment, L.P. and another investor CI
27/07 AsymBio, Subsidiary of Asymchem Group Kicks Off Construction of Fengxian R&D Building CI
10/07 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy MT
10/07 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$131.48 From HK$115.43, Keeps at Buy MT
12/06 Asymchem Laboratories Co., Ltd. Approves Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on June 26, 2026 CI
27/05 Asymbio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates CI
20/05 Citigroup's long position in H shares of Asymchem Laboratories (Tianjin) decreases to 4.99% on May 14 from 5.66%, HKEX filing says RE
15/05 Asymchem Laboratories Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2025, Payable on 24 July 2026 CI
13/05 Citigroup's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 5.36% on May 7, HKEX says RE
04/05 JPMorgan Chase's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 7.64% on Apr 28 from 8.18%, HKEX filing shows RE
28/04 Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8% MT
28/04 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
1 day-0.36%
1 week+7.11%
Current month+14.64%
1 month+5.80%
3 months+35.77%
6 months+69.16%
Current year+88.31%
1 week 156
Extreme 156
188
1 month 142.43
Extreme 142.43
200
Current year 91.33
Extreme 91.33
200
1 year 88.46
Extreme 88.46
200
3 years 59.55
Extreme 59.55
200
5 years 59.55
Extreme 59.55
380.35
10 years 13.09
Extreme 13.085713
380.35
Manager TitleAgeSince
Chief Executive Officer 70 07/10/1998
Chief Executive Officer 49 19/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 18/07/2011
Chairman 70 07/10/1998
Director/Board Member 65 18/07/2011
Date Insider Type Main position Quantity % Market Cap.
14/07/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany -3,15,000 1.1317%
08/07/26 Other

Chief Executive Officer

25,000 0.0898%
08/07/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany 25,000 0.0898%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%+7.11%+72.91%+35.38% 908.92Cr
+0.43%+4.31%+90.84%+130.99% 1,08300Cr
+0.41%+1.27%+50.98%+50.05% 63TCr
-0.53%+1.04%+25.23%+63.46% 44TCr
-0.92%+0.22%+48.34%+37.85% 36TCr
-1.32%-0.21%+29.07%+36.81% 29TCr
-1.20%-2.78%+5.56%+6.09% 25TCr
+0.45%+2.05%+46.04%+58.54% 22TCr
-2.51%+1.77%-6.55%-51.74% 21TCr
+0.07%+3.12%+13.21%+69.84% 17TCr
Average -0.55%+2.54%+37.56%+43.73% 36.68TCr
Weighted average by Cap. -0.26%+2.22%+49.28%+65.89%

Financials

2026 *2027 *
Net sales 808.17Cr 119.84Cr 103.83Cr 97Cr 89Cr 166.82Cr 11TCr 169.38Cr 1.14TCr 447.26Cr 5.72TCr 449.95Cr 440.17Cr 19TCr 972.16Cr 144.16Cr 124.9Cr 117.02Cr 106.74Cr 200.67Cr 14TCr 203.75Cr 1.38TCr 538.01Cr 6.88TCr 541.26Cr 529.49Cr 23TCr
Net income 140.21Cr 21Cr 18Cr 17Cr 15Cr 29Cr 1.98TCr 29Cr 198.5Cr 78Cr 992.93Cr 78Cr 76Cr 3.31TCr 176.93Cr 26Cr 23Cr 21Cr 19Cr 37Cr 2.5TCr 37Cr 250.49Cr 98Cr 1.25TCr 99Cr 96Cr 4.18TCr
Net Debt -504.94Cr -75Cr -65Cr -61Cr -55Cr -104.23Cr -7.14TCr -105.83Cr -714.88Cr -279.44Cr -3.58TCr -281.13Cr -275.02Cr -12TCr -439.22Cr -65Cr -56Cr -53Cr -48Cr -91Cr -6.21TCr -92Cr -621.84Cr -243.07Cr -3.11TCr -244.54Cr -239.23Cr -10TCr
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Date Price Change Volume
12/26/12 CN¥175.00 -0.36% 1,11,08,829
11/26/11 CN¥175.64 -0.20% 1,83,99,012
10/26/10 CN¥176.00 +2.17% 2,32,82,185
07/26/07 CN¥172.26 +10.00% 1,08,45,091
06/26/06 CN¥156.60 -4.15% 1,35,13,117
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
175.00CNY
Average target price
160.45CNY
Spread / Average Target
-8.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002821 Stock